An observational study in Cardiac Arrest, Transcatheter Aortic Valve Implantation, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Status unknown at 1 site in China. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2020-12-29.
Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Observational
This study was aimed to investigate the clinical characteristics, management and prognosis of patients developing intraoperative cardiac arrest during transcatheter aortic valve implantation
966 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.
This study's planned enrollment of 20 is below the median of 200 across 383 observational studies indexed under Heart Arrest.
Browse Heart Arrest studies →Second Affiliated Hospital, School of Medicine, Zhejiang University is the lead sponsor of 1,058 studies on the registry; 511 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients who developed intraoperative cardiac arrest during transcatheter aortic valve implantation from January 2014 to May 2019
Inclusion Criteria: patients who developed intraoperative cardiac arrest during transcatheter aortic valve implantation from January 2014 to May 2019 -
Exclusion Criteria: None.
-
Including patients developing intraoperative cardiac arrest during transcatheter aortic valve implantation from January 2014 to May 2019
Other: follow up and record
None additional intervention was applied to the subjects.
Mortality
In-hospital mortality
Time frame: 1month
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Second Affiliated Hospital, School of Medicine, Zhejiang University